Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats
about
The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat.A low-carbohydrate/high-fat diet reduces blood pressure in spontaneously hypertensive rats without deleterious changes in insulin resistance.Captopril: pharmacology, metabolism and disposition.Effects of captopril in animal models of hypertension.Development of a new procedure for the determination of captopril in pharmaceutical formulations employing chemiluminescence and a multicommuted flow analysis approach.Captopril inhibits tumour growth in a xenograft model of human renal cell carcinomaPharmacological properties of FPL 63547, a novel inhibitor of angiotensin-converting enzyme.Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 in spontaneously hypertensive rats.Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats.Comparative effects of hydralazine and captopril on the cardiovascular changes in spontaneously hypertensive rats.The effect of captopril treatment and its withdrawal on the gene expression of the renin-angiotensin system.Studies on the mechanism of the enhancement of the antihypertensive activity of captopril by a diuretic in spontaneously hypertensive rats.Captopril and hypertension development in the SHR.
P2860
Q35883217-A82088C4-0B53-4A60-9A54-1E3483C8E628Q36296915-723571E0-DEFF-4CC9-B84F-1AA1365DD7EAQ36923932-85B46FAE-94DA-4BD8-BA37-EBF2C68BA97DQ40214810-E3E9E83C-FDA9-4789-B75D-F4F73F6814A5Q40292890-21C88DF1-E28E-406D-A954-A5AFBAA55F2AQ40774520-B8EBEA70-C5C7-47A0-BF79-5C7A5818E421Q41053553-AF6767D0-184D-45BA-806D-D044150B90B2Q41853352-C6D43703-F547-4FC1-B9AA-DC4F7D548844Q42244973-C1448C0C-86D5-49EF-8FE7-53C219DFE60DQ42636392-E6CD22EC-D7B9-4755-BE98-56262D539CA0Q42737668-7294F75A-E2F7-45D3-A377-ED424478D707Q53951496-F81F4E56-FF05-48EA-9508-88F0523E1996Q54526156-C9A3E2BB-BD6F-4178-9978-A157F083A618Q54561592-A936FDE2-F7A0-454C-BB30-DAB35DF08A3D
P2860
Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats
description
1979 nî lūn-bûn
@nan
1979 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
name
Effects of chronic treatment w ...... pontaneously hypertensive rats
@ast
Effects of chronic treatment w ...... pontaneously hypertensive rats
@en
Effects of chronic treatment w ...... pontaneously hypertensive rats
@nl
type
label
Effects of chronic treatment w ...... pontaneously hypertensive rats
@ast
Effects of chronic treatment w ...... pontaneously hypertensive rats
@en
Effects of chronic treatment w ...... pontaneously hypertensive rats
@nl
prefLabel
Effects of chronic treatment w ...... pontaneously hypertensive rats
@ast
Effects of chronic treatment w ...... pontaneously hypertensive rats
@en
Effects of chronic treatment w ...... pontaneously hypertensive rats
@nl
P2093
P356
P1476
Effects of chronic treatment w ...... pontaneously hypertensive rats
@en
P2093
D N Harris
M E Goldberg
M J Antonaccio
R J Laffan
Z P Horovitz
P304
P356
10.1254/JJP.29.285
P407
P577
1979-04-01T00:00:00Z